World Health Summit 2022

“The AMR preclinical pipeline is very innovative but also very fragile.”

These were the words of Dr Ralf Sudbrak, representing the Global Antimicrobial Resistance (AMR) Research and Development (R&D) Hub at the World Health Summit 2022 session on Partnerships and AMR: Identifying Challenges and Opportunities Across the Antibiotic R&D and Access Value Chain.

The session was chaired by Dr. Laura Jung and speakers were as follows:

➜ Dr. Manica Balasegaram, Global Antibiotic Research and Development Partnership

➜ Dr. Erin Duffy, CARB-X

➜ Dr. Martin Fitchet, Johnson & Johnson

➜ Dr. Valeria Gigante, World Health Organization

➜ Dr. Ralf Sudbrak, Global AMR R&D Hub


Curious about more?

You can sign up for our newsletter here. By subscribing, you automatically provide your consent for the use of your data in accordance with our privacy policy.

This field is for validation purposes and should be left unchanged.

Latest news

Go to all news
Dynamic Dashboard